<DOC>
	<DOCNO>NCT02340572</DOCNO>
	<brief_summary>AnticalinsÂ® engineer human protein able bind specific target molecule . The Anticalin PRS-080 # 022-DP investigate study direct hepcidin intend treatment anemia chronic disease . This phase I First-in-Human study shall investigate safety pharmacokinetics healthy human volunteer .</brief_summary>
	<brief_title>First-in-Human Study Evaluate Safety , Tolerability , Pharmacokinetics Pharmacodynamics PRS-080</brief_title>
	<detailed_description>First-in-Human ( FIH ) , randomize , dose-escalation , double-blind , placebo-controlled single dose healthy volunteer . The single rising dose study enroll 8 subject per cohort ( 6 verum , 2 placebo ) , maximum tolerate dose , define stopping rule . 6 dose level anticipate . Study drug administer i.v . infusion Day 1 . The decision escalate dose dose escalation committee ( DEC ) base interim analysis clinical safety safety laboratory data .</detailed_description>
	<criteria>1 . Healthy Caucasian male : base screen examination include medical history , physical examination , 12lead ECG , vital sign clinical laboratory profile , age 1850 year 2 . Subjects body mass index 1830 kg/m2 weigh 6090 kg 3 . Subjects must use two acceptable method contraception ( e.g . spermicide condom ) study refrain father child 3 month follow last dosing . 4 . Willing comply requirement study protocol signing informed consent sheet . 1 . Any uncontrolled active major systemic disease 2 . History presence malignancy 3 . Definite suspect history drug allergy 4 . Active acute chronic infection , include , limited : upper airway infection , urinary tract infection , skin infection 5 . Use investigational drug within 30 day , 5 halflives , whichever longer , prior plan first drug administration . 6 . Use prescription medication within 14 day prior plan first drug administration throughout study ( exception medication give treat adverse event use nonprescription overthecounter medication within 7 day prior plan first drug administration throughout study ( include vitamin , herbal supplement , remedy 7 . Smoking great 20 cigarette per week 8 . History alcohol substance abuse within past 6 month prior plan first drug administration 9 . History increase bleed risk 10 . Clinically relevant abnormality find physical examination , vital sign measurement , laboratory safety test ECG 11 . Blood donation within last 60 day prior plan first drug administration 12 . Positive result hepatitis B surface antigen , hepatitis C antibody , human immunodeficiency virus ( HIV1/2 ) antibodies screen 13 . Iron overload disturbance utilization iron ( define ferritin &gt; 300.0 ng/mL &lt; 10.0 ng/mL ) 14. i.v . iron treatment blood transfusion within last 90 day prior plan first drug administration trial 15 . ESA ( e.g . Erythropoietin ) treatment within last year 16 . Surgery trauma significant blood loss within 2 month plan first drug administration 17 . Not able abstain consumption food beverage know influence dietary iron absorption</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>